164 related articles for article (PubMed ID: 31344718)
1. Ovarian Sertoli-Leydig Cell Tumors: Epidemiological, Clinical and Prognostic Factors.
Castro BGR; Souza CP; Andrade CEMDC; Vieira MA; Andrade DAP; Reis RD
Rev Bras Ginecol Obstet; 2019 Jul; 41(7):440-448. PubMed ID: 31344718
[TBL] [Abstract][Full Text] [Related]
2. Results from a Monocentric Long-Term Analysis of 23 Patients with Ovarian Sertoli-Leydig Cell Tumors.
Gouy S; Arfi A; Maulard A; Pautier P; Bentivegna E; Leary A; Chargari C; Genestie C; Morice P
Oncologist; 2019 May; 24(5):702-709. PubMed ID: 30201740
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the Prognostic Outcome between High-Grade Ovarian Sertoli-Leydig Cell Tumors (SLCTs) and Low-Grade SLCTs.
Eoh KJ; Park J; Kim HM; Lee M; Kim YT
Yonsei Med J; 2021 Apr; 62(4):366-369. PubMed ID: 33779091
[TBL] [Abstract][Full Text] [Related]
4. Ovarian sertoli-leydig cell tumors: A multicenter long-term clinicopathological analysis of 27 patients.
Akman L; Ertas IE; Gokcu M; Terek MC; Sanci M; Sanli UA; Zekioglu O; Ozsaran AA
J Cancer Res Ther; 2016; 12(1):290-4. PubMed ID: 27072253
[TBL] [Abstract][Full Text] [Related]
5. A clinicopathological analysis of 40 cases of ovarian Sertoli-Leydig cell tumors.
Gui T; Cao D; Shen K; Yang J; Zhang Y; Yu Q; Wan X; Xiang Y; Xiao Y; Guo L
Gynecol Oncol; 2012 Nov; 127(2):384-9. PubMed ID: 22850410
[TBL] [Abstract][Full Text] [Related]
6. Sertoli-Leydig cell tumor of the ovary: Analysis of a single institution database and review of the literature.
Durmuş Y; Kılıç Ç; Çakır C; Yüksel D; Boran N; Karalök A; Boyraz G; Turan AT
J Obstet Gynaecol Res; 2019 Jul; 45(7):1311-1318. PubMed ID: 31106943
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and outcomes analysis of ovarian Sertoli-Leydig cell tumors (SLCTs): analysis of 15 patients.
Wang G; Zhang R; Li C; Chen A
J Ovarian Res; 2021 Nov; 14(1):150. PubMed ID: 34736487
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic features of ovarian Sertoli-Leydig cell tumors.
Zhang HY; Zhu JE; Huang W; Zhu J
Int J Clin Exp Pathol; 2014; 7(10):6956-64. PubMed ID: 25400781
[TBL] [Abstract][Full Text] [Related]
9. Ovarian Sertoli-Leydig cell tumours: How typical is their typical presentation?
Melero Cortés LM; Martínez Maestre MÁ; Vieites Pérez-Quintela MB; Gambadauro P
J Obstet Gynaecol; 2017 Jul; 37(5):655-659. PubMed ID: 28485183
[TBL] [Abstract][Full Text] [Related]
10. Sertoli-Leydig cell tumor: a clinicopathological analysis in a comprehensive, national cohort.
Bekker P; Miland-Samuelsen AR; Smerdel MP; Schnack TH; Lauszus FF; Karstensen SH
Int J Gynecol Cancer; 2023 Dec; 33(12):1921-1927. PubMed ID: 37907261
[TBL] [Abstract][Full Text] [Related]
11. Ovarian Sertoli-Leydig cell tumors. a retrospective MITO study.
Sigismondi C; Gadducci A; Lorusso D; Candiani M; Breda E; Raspagliesi F; Cormio G; Marinaccio M; Mangili G
Gynecol Oncol; 2012 Jun; 125(3):673-6. PubMed ID: 22446621
[TBL] [Abstract][Full Text] [Related]
12. Ovarian Sertoli Leydig cell tumours in children and adolescents: an analysis of the European Cooperative Study Group on Pediatric Rare Tumors (EXPeRT).
Schneider DT; Orbach D; Cecchetto G; Stachowicz-Stencel T; Brummel B; Brecht IB; Bisogno G; Ferrari A; Reguerre Y; Godzinski J; Bien E; Calaminus G; Göbel U; Patte C
Eur J Cancer; 2015 Mar; 51(4):543-550. PubMed ID: 25514863
[TBL] [Abstract][Full Text] [Related]
13. Ovarian Sertoli-Leydig cell tumors: an analysis of 13 cases.
Guo Y; Wang J; Li Y; Wang Y
Arch Gynecol Obstet; 2020 Jul; 302(1):203-208. PubMed ID: 32430758
[TBL] [Abstract][Full Text] [Related]
14. Sertoli-Leydig cell tumors of the ovary: a Taiwanese Gynecologic Oncology Group study.
Weng CS; Chen MY; Wang TY; Tsai HW; Hung YC; Yu KJ; Chiang YC; Lin H; Lu CH; Chou HH
Taiwan J Obstet Gynecol; 2013 Mar; 52(1):66-70. PubMed ID: 23548221
[TBL] [Abstract][Full Text] [Related]
15. Ovarian Sertoli-Leydig and granulosa cell tumor: comparison of epidemiology and survival outcomes.
Nasioudis D; Mastroyannis SA; F Haggerty A; M Ko E; Latif NA
Arch Gynecol Obstet; 2020 Aug; 302(2):481-486. PubMed ID: 32519016
[TBL] [Abstract][Full Text] [Related]
16. Sertoli-Leydig cell tumors of ovary: A case series.
Xu Q; Zou Y; Zhang XF
Medicine (Baltimore); 2018 Oct; 97(42):e12865. PubMed ID: 30334998
[TBL] [Abstract][Full Text] [Related]
17. Sertoli-Leydig cell tumor of the ovary: analysis of a single institution database.
Bhat RA; Lim YK; Chia YN; Yam KL
J Obstet Gynaecol Res; 2013 Jan; 39(1):305-10. PubMed ID: 22691037
[TBL] [Abstract][Full Text] [Related]
18. Sertoli-Leydig cell tumor in two siblings with DICER1 syndrome: A case report and literature review.
Zhang Y; Ren M; Hong Y; Zhong Y; Cong X; Chen C; Liu Z; Man Y; Yang L
Medicine (Baltimore); 2020 Jul; 99(27):e20806. PubMed ID: 32629665
[TBL] [Abstract][Full Text] [Related]
19. Contribution of lymph node staging method and prognostic factors in malignant ovarian sex cord-stromal tumors: A world wide database analysis.
Wang J; Li J; Chen R; Lu X
Eur J Surg Oncol; 2018 Jul; 44(7):1054-1061. PubMed ID: 29705285
[TBL] [Abstract][Full Text] [Related]
20. Management of metastatic ovarian Sertoli-Leydig cell tumor with sporadic multinodular goiter: a case report and literature review.
Chi M; Gilman AD; Iroegbu N
Future Oncol; 2011 Sep; 7(9):1113-7. PubMed ID: 21919698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
